Search

Your search keyword '"Patel SK"' showing total 713 results

Search Constraints

Start Over You searched for: Author "Patel SK" Remove constraint Author: "Patel SK"
713 results on '"Patel SK"'

Search Results

1. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

2. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

10. Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2 (vol 13, 889372, 2022)

13. Plasma Angiotensin Converting Enzyme 2 (ACE2) Activity in Healthy Controls and Patients with Cardiovascular Risk Factors and/or Disease

14. Adolescent transport and unintentional injuries: a systematic analysis using the Global Burden of Disease Study 2019

15. Plasma Neurofilament Light Chain and Clinical Diagnosis in Frontotemporal Dementia Syndromes

17. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019

19. Plasma ACE2 activity is persistently elevated following SARS-CoV-2 infection: implications for COVID-19 pathogenesis and consequences

20. Global injury morbidity and mortality from 1990 to 2017: results from the Global Burden of Disease Study 2017

21. Reduced urinary levels of angiotensin-converting enzyme 2 activity predict acute kidney injury in critically ill patients

22. Estimating global injuries morbidity and mortality: methods and data used in the Global Burden of Disease 2017 study.

24. Apoptosis and Other Alternate Mechanisms of Cell Death

25. Kruppel-Like Factor 15 Is Critical for the Development of Left Ventricular Hypertrophygj

26. Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease

27. Left ventricular hypertrophy in experimental chronic kidney disease is associated with reduced expression of cardiac Kruppel-like factor 15

28. Experimental and Human Evidence for Lipocalin-2 (Neutrophil Gelatinase-Associated Lipocalin [NGAL]) in the Development of Cardiac Hypertrophy and heart failure

29. Does left ventricular hypertrophy affect cognition and brain structural integrity in type 2 diabetes? Study design and rationale of the Diabetes and Dementia (D2) study

30. Genetic Variation in Kruppel like Factor 15 Is Associated with Left Ventricular Hypertrophy in Patients with Type 2 Diabetes: Discovery and Replication Cohorts

32. Diminazene Aceturate Improves Cardiac Fibrosis and Diastolic Dysfunction in Rats with Kidney Disease

33. The Receptor for Advanced Glycation End Products (RAGE) Is Associated with Persistent Atrial Fibrillation

34. The impact of pediatric blood and marrow transplant on parents: Introduction of the parent impact scale

35. Short-Term Treatment with Diminazene Aceturate Ameliorates the Reduction in Kidney ACE2 Activity in Rats with Subtotal Nephrectomy

36. Synthesis and characterization of bridged and chelated diphosphine coordinated transition metal chalcogenide clusters, [(CO)(18)Fe-6(mu(3)-Te)(4){mu-PPh2(CH2)(2)PPh2}] and [(CO)(n)Fe-2(mu(3)-Y)(2)M{PPh2-R-PPh2}], [Y = Se, Te; M = Pd, Fe; n=6, 8; R = {(eta(5)-C5H4)(2)Fe}, {(CH2)(2)}]

38. Prevalence, predictors and evolution of echocardiographically defined cardiac abnormalities in adults with type 1 diabetes: an observational cohort study

39. From gene to protein-experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension

40. Emerging markers in cardiovascular disease: Where does angiotensin-converting enzyme 2 fit in?

41. Chronic kidney disease: cardiac and renal angiotensin-converting enzyme (ACE) 2 expression in rats after subtotal nephrectomy and the effect of ACE inhibition

42. The CTGF gene-945 G/C polymorphism is not associated with cardiac or kidney complications in subjects with type 2 diabetes

43. Pharmacology of AMG 181, a human anti-α4β7antibody that specifically alters trafficking of gut-homing T cells

Catalog

Books, media, physical & digital resources